Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene |
| |
Authors: | Lane Hsien-Yuan Chang Yue-Cune Chiu Chih-Chiang Chen Mao-Liang Hsieh Min-Hua Chang Wen-Ho |
| |
Affiliation: | Department of Psychiatry, Tzu-Chi General Hospital, Institute of Neuroscience, Tzu-Chi University, Hualien City, Taiwan. |
| |
Abstract: | OBJECTIVE: This study investigated the effect of the 102-T/C polymorphism in the 5-HT(2A) receptor gene on risperidone efficacy. METHOD: One hundred Han Chinese patients with acutely exacerbated schizophrenia were given risperidone for up to 42 days. The patients were genotyped for 5-HT(2A) polymorphisms. Psychopathology was measured biweekly with the Positive and Negative Syndrome Scale while the patients were taking risperidone. Generalized estimating equation methods were used to analyze the effects of treatment duration, T/C genotypes, and other prognostic factors on Positive and Negative Syndrome Scale performance. RESULTS: Patients with the C/C genotype had lower total scores, negative subscale scores, and general psychopathology scores but not positive subscale scores on the Positive and Negative Syndrome Scale than patients with the 102-T/C genotype. Patients with the T/C and T/T genotypes had comparable total and subscale scores. The number of previous hospitalizations and the dose of risperidone also affected Positive and Negative Syndrome Scale total scores. CONCLUSIONS: These results suggest that variations in the 5-HT(2A) receptor gene may influence individual responses to risperidone. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|